Compare Cassava Sciences Inc (FLNA) vs Motorola Solutions Inc (MSI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cassava Sciences Inc vs Motorola Solutions Inc — how do they compare? Cassava Sciences Inc trades at $0.82 (market cap $39.40M), while Motorola Solutions Inc trades at $446.82 (market cap $74.20B). The key difference: Motorola Solutions Inc is far larger — about 1883.2× Cassava Sciences Inc's market cap, and Motorola Solutions Inc pays a 1.08% dividend while Cassava Sciences Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Cassava Sciences Inc for 37 Days and Motorola Solutions Inc for 100 Days on average.
| FLNA | MSI | |
|---|---|---|
Market Cap | $39.40M | $74.20B |
Volume | 759,018 | 720,826 |
Sector | Health | Technology |
52-Week High | $4.64 | $491.24 |
52-Week Low | $0.68 | $363.83 |
Typical Hold Time | 37 Days | 100 Days |
Enterprise Value | -$43.28M | $83.10B |
Dividend Yield | — | 1.08% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
FLNA trades at $0.8136, down 7.01% today, with a bearish technical signal from moving averages. The company shows negative profitability with ROE at -55.79% and ROA at -35.34%, though it has beaten EPS estimates for three consecutive quarters. Recent FDA approval to lift the clinical hold on simufilam for epilepsy research provides a positive catalyst, with patient screening expected by Q1 2027.
Despite operational losses and negative cash flow, analyst consensus is bullish with 8 buy ratings versus 4 hold. The key investment opportunity lies in the clinical progress of simufilam, while risks include sustained cash burn and reliance on successful drug development outcomes in a competitive biotech landscape.
Motorola Solutions (MSI) trades at $447.12, down 2.02% today, amid a bearish technical signal. The company maintains strong fundamentals with Q2 2026 EPS of $4.41 beating expectations and record backlog of $15.6 billion. Recent acquisitions including D-Fend Solutions for $1.5 billion expand its counter-drone security capabilities, while new contracts with Louisiana and the US Navy demonstrate ongoing demand.
MSI presents a compelling growth story with robust earnings momentum and strategic expansion, though elevated valuation ratios and significant capital expenditures pose risks. Analyst consensus remains bullish with a $525.86 price target, representing 17.6% upside potential from current levels.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Cassava Sciences Inc
Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease
Read more on FLNA →About Motorola Solutions Inc
Motorola Solutions, Inc. is a data communications and telecommunications equipment provider. The Company develops data capture, wireless, infrastructure, bar code scanning, two-way radios, and wireless broadband networks. Motorola also produces public safety and government products, voice and data communications products and systems, and wireless LAN securities.
Read more on MSI →
